Barrington Research reaffirmed their outperform rating on shares of Healthways Inc. (NASDAQ:HWAY) in a research note published on Thursday morning. Barrington Research currently has a $30.00 target price on the stock, up from their prior target price of $29.00.

A number of other research firms also recently weighed in on HWAY. Zacks Investment Research cut Healthways from a buy rating to a hold rating in a research report on Tuesday, September 20th. Barclays PLC raised Healthways from an underweight rating to an equal weight rating and increased their price target for the company from $12.00 to $27.00 in a report on Monday, August 22nd. Jefferies Group set a $26.00 price target on Healthways and gave the company a hold rating in a report on Thursday, August 18th. Oppenheimer Holdings Inc. raised Healthways to an outperform rating and set a $27.00 price target on the stock in a report on Sunday, August 14th. Finally, FBR & Co increased their price target on Healthways from $16.00 to $21.00 and gave the company an outperform rating in a report on Wednesday, August 10th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of Buy and an average price target of $26.50.

Analyst Recommendations for Healthways (NASDAQ:HWAY)

Healthways (NASDAQ:HWAY) traded up 0.40% during trading on Thursday, hitting $25.06. The stock had a trading volume of 136,780 shares. The stock has a 50 day moving average of $25.34 and a 200 day moving average of $16.38. Healthways has a one year low of $9.18 and a one year high of $27.30. The firm’s market capitalization is $920.65 million.

Healthways (NASDAQ:HWAY) last released its earnings results on Tuesday, August 9th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.53. Healthways had a positive return on equity of 8.83% and a negative net margin of 31.32%. The company earned $125 million during the quarter, compared to analyst estimates of $186.88 million. During the same quarter in the previous year, the company posted $0.11 EPS. Healthways’s revenue for the quarter was up 10.2% on a year-over-year basis. Equities research analysts expect that Healthways will post $2.11 earnings per share for the current fiscal year.

In other Healthways news, Director Mary Jane England sold 3,816 shares of the company’s stock in a transaction dated Friday, August 26th. The shares were sold at an average price of $24.78, for a total value of $94,560.48. Following the completion of the transaction, the director now owns 39,068 shares in the company, valued at $968,105.04. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 14.01% of the company’s stock.

Several hedge funds have recently bought and sold shares of the stock. Acrospire Investment Management LLC raised its stake in Healthways by 80.9% in the second quarter. Acrospire Investment Management LLC now owns 9,612 shares of the company’s stock worth $111,000 after buying an additional 4,300 shares during the period. Quantitative Systematic Strategies LLC acquired a new stake in Healthways during the second quarter worth about $118,000. Profund Advisors LLC raised its stake in Healthways by 4.5% in the second quarter. Profund Advisors LLC now owns 10,668 shares of the company’s stock worth $123,000 after buying an additional 456 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its stake in Healthways by 7.6% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 11,685 shares of the company’s stock worth $135,000 after buying an additional 825 shares during the period. Finally, KBC Group NV acquired a new stake in Healthways during the second quarter worth about $147,000. 92.52% of the stock is owned by institutional investors and hedge funds.

Healthways Company Profile

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

5 Day Chart for NASDAQ:HWAY

Receive News & Stock Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related stocks with our FREE daily email newsletter.